Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Glycol salicylate is a salicylate used to treat mild to moderate muscle pain. Glycol salicylate, also known as 2-hydroxyethyl salicylate, is a benzoate ester formed from the condensation of the carboxy group of salicylic acid with one of the hydroxy groups of ethylene glycol.
- Mechanism
- Curator reviewed · 1 reference
Similar to other salicylates. Salicylates and other analgesics and anti-inflammatory drugs, particularly the non-steroidal anti-inflammatory drugs (NSAID) mainly used in rheumatology, inhibit cyclooxygenase, therefore reducing prostaglandin synthesis.
- Primary indication
- This drug is only recommended for topical usages for the relief of muscular and rheumatic pain in human and animals.Curator reviewed · 8 structured indications
- Formula / weight
- C9H10O4 · 182.175 g/mol (avg)
- First approval
- Canada, 2000
- Also known as
- 2-hydroxyethyl salicylate · Ethylene glycol monosalicylate · Ethylene glycol salicylate
Resolves to
LVYLCBNXHHHPSB-UHFFFAOYSA-NSMILESOCCOC(=O)C1=CC=CC=C1OWhat you can answer from here — as of February 21, 2021
Which drugs share a target with Glycol salicylate, and which of those have an active Phase 3 trial?